'''''para''-Chloroamphetamine''' ('''PCA'''), also known as '''4-chloroamphetamine''' ('''4-CA'''), is a [[substituted amphetamine]] and [[monoamine]] [[releasing agent|releaser]] similar to [[MDMA]], but with substantially higher [[neurotoxicity]], thought to be due to the unrestrained release of both [[serotonin]] and [[dopamine]] by a metabolite.<ref>{{Cite journal | last1 = Miller | first1 = K. J. | last2 = Anderholm | first2 = D. C. | last3 = Ames | first3 = M. M. | doi = 10.1016/0006-2952(86)90332-1 | title = Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations | journal = Biochemical Pharmacology | volume = 35 | issue = 10 | pages = 1737–1742 | year = 1986 | pmid =  3707603| pmc = }}</ref> It is used as a [[neurotoxin]] by neurobiologists to selectively kill [[serotonergic]] [[neuron]]s for research purposes, in the same way that [[6-hydroxydopamine]] is used to kill [[dopaminergic]] neurons.<ref>{{cite journal | pmid=125387| year=1975| author1=Gal| first1=E. M.| title=Effect of p-chloroamphetamine on cerebral tryptophan-5-hydroxylase in vivo: A reexamination| journal=Neuropharmacology| volume=14| issue=1| pages=31–9| last2=Cristiansen| first2=P. A.| last3=Yunger| first3=L. M.| doi=10.1016/0028-3908(75)90063-5}}</ref><ref>{{cite journal | pmid=80243| pmc=1668117| year=1978| author1=Curzon| first1=G| title=5-Hydroxytryptamine: The effects of impaired synthesis on its metabolism and release in rat| journal=British Journal of Pharmacology| volume=63| issue=4| pages=627–34| last2=Fernando| first2=J. C.| last3=Marsden| first3=C. A.| doi=10.1111/j.1476-5381.1978.tb17275.x}}</ref><ref>{{cite journal | pmid=7682129| pmc=1908028| year=1993| author1=Colado| first1=M. I.| title=5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine| journal=British Journal of Pharmacology| volume=108| issue=3| pages=583–9| last2=Murray| first2=T. K.| last3=Green| first3=A. R.| doi=10.1111/j.1476-5381.1993.tb12846.x}}</ref><ref>{{cite journal | pmid=8602894| year=1995| author1=Freo| first1=U| title=Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in rats| journal=Neuropsychopharmacology| volume=13| issue=3| pages=215–22| last2=Pietrini| first2=P| last3=Pizzolato| first3=G| last4=Furey| first4=M| last5=Merico| first5=A| last6=Ruggero| first6=S| last7=Dam| first7=M| last8=Battistin| first8=L| doi=10.1016/0893-133X(95)00053-G}}</ref>

 
However, the effects of the compound on experimental animals appear less encouraging.<ref>{{cite book | author = Alexander T. Shulgin  | title = Handbook of Psychopharmacology | volume = 11: Stimulants |editor1=Leslie L. Iversen |editor2=Susan D. Iversen |editor3=Solomon H. Snyder | publisher = Plenum Press | location = New York | date = 1978 | url = http://www.erowid.org/archive/rhodium/chemistry/shulgin.pea.sar.hop.html#35}}</ref> It has been detected as an apparent [[designer drug]],<ref>{{cite journal | vauthors = Lin TC, Lin DL, Lua AC | title = Detection of p-chloroamphetamine in urine samples with mass spectrometry | journal = Journal of Analytical Toxicology | date = 2011 | volume = 35 | issue = 4 | pages = 205–210 | pmid=21513613| doi=10.1093/anatox/35.4.205}}</ref> along with the related [[3-Chloroamphetamine|3-chloroamphetamine]], which is even more potent as a releaser of dopamine and serotonin but slightly less neurotoxic.<ref>{{Cite journal | last1 = Fuller | first1 = R. | last2 = Schaffer | first2 = R. J. | last3 = Roush | first3 = B. W. | last4 = Molloy | first4 = B. B. | title = Drug disposition as a factor in the lowering of brain serotonin by chloroamphetamines in the rat | doi = 10.1016/0006-2952(72)90365-6 | journal = Biochemical Pharmacology | volume = 21 | issue = 10 | pages = 1413–1417 | year = 1972 | pmid =  5029422| pmc = }}</ref><ref>{{Cite journal | last1 = Ögren | first1 = S. O. | last2 = Ross | first2 = S. B. | doi = 10.1111/j.1600-0773.1977.tb02674.x | title = Substituted Amphetamine Derivatives. II. Behavioural Effects in Mice Related to Monoaminergic Neurones | journal = Acta Pharmacologica et Toxicologica | volume = 41 | issue = 4 | pages = 353–368 | year = 2009 | pmid =  303437| pmc = }}</ref><ref>{{Cite journal | last1 = Ross | first1 = S. B. | last2 = Kelder | first2 = D. | doi = 10.1111/j.1600-0773.1979.tb02339.x | title = Inhibition of 3H-Dopamine Accumulation in Reserpinized and Normal Rat Striatum | journal = Acta Pharmacologica et Toxicologica | volume = 44 | issue = 5 | pages = 329–335 | year = 2009 | pmid =  474143| pmc = }}</ref><ref>{{Cite journal | last1 = Fuller | first1 = R. W. | last2 = Baker | first2 = J. C. | doi = 10.1111/j.2042-7158.1974.tb09206.x | title = Long-lasting reduction of brain 5-hydroxytryptamine concentration by 3-chloroamphetamine and 4-chloroamphetamine in iprindole-treated rats | journal = Journal of Pharmacy and Pharmacology | volume = 26 | issue = 11 | pages = 912–914 | year = 1974 | pmid =  4156568| pmc = }}</ref><ref>{{Cite journal | last1 = Ross | first1 = S. B. | last2 = Ögren | first2 = S. O. | last3 = Renyi | first3 = A. L. | doi = 10.1111/j.1600-0773.1977.tb02673.x | title = Substituted Amphetamine Derivatives. I. Effect on Uptake and Release of Biogenic Monoamines and on Monoamine Oxidase in the Mouse Brain | journal = Acta Pharmacologica et Toxicologica | volume = 41 | issue = 4 | pages = 337–352 | year = 2009 | pmid =  579062| pmc = }}</ref>
